inside the quickly evolving industry of cancer therapeutics, comprehending the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is important for building effective therapies. Among the most promising strategies is using in vitro bystander impact assays, which Engage in a pivotal position in maximizing therapeutic efficacy. These assays, furn